Sectoral Asset Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Sectoral Asset Management’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-31,629	Closed	-$2.57M	–	73
2019 Q4	$2.57M	Sell	31,629 -5,000	-14%	-$559K	0.38%	55
2019 Q3	$4.47M	Buy	36,629 +3,160	+9%	+$434K	0.77%	45
2019 Q2	$6.01M	Buy	33,469 +915	+3%	+$148K	0.72%	50
2019 Q1	$5.21M	Buy	32,554 +12,195	+60%	+$2.41M	0.63%	56
2018 Q4	$5.3M	Hold	20,359	–	–	0.72%	48
2018 Q3	$4.96M	Sell	20,359 -1,516	-7%	-$397K	0.53%	54
2018 Q2	$5.16M	Buy	+21,875	New	+$6.38M	0.58%	50

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sectoral Asset Management's EVLO Position: Q1 2020 in Review

Sectoral Asset Management sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q1 2020, closing a stake of 31,629 shares — an estimated $2.57M sold.

Sectoral Asset Management first reported a position in EVLO in Q2 2018 and held it in 7 quarters. The position peaked at $6.01M in Q2 2019. 42 funds tracked by Wall St. Rank hold EVLO as of Q1 2020.

Sectoral Asset Management reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Sectoral Asset Management sold 31,629 Evelo Biosciences, Inc. Common Stock shares in Q1 2020, an estimated $2.57M.
Sectoral Asset Management first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 7 quarters.
Sectoral Asset Management's Evelo Biosciences, Inc. Common Stock position peaked at $6.01M in Q2 2019.
42 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q1 2020.

Based on Sectoral Asset Management's 13F filing for Q1 2020, filed 13 May 2020.